A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design

Chemistry and Biology

Volumn 19, Issue 2, 2012, Pages 254-263

  Clark, Brenda E ^a   Auyeung, Kate ^a   Fregolino, Eleonora ^b   Parrilli, Michelangelo ^b   Lanzetta, Rosa ^b   De Castro, Cristina ^b   Pantophlet, Ralph ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL LIPOOLIGOSACCHARIDE; EPITOPE; GLYCOCONJUGATE; LIPOOLIGOSACCHARIDE; MANNOSE OLIGOSACCHARIDE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; SEQUENCE ANALYSIS;

AIDS VACCINES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CARBOHYDRATE SEQUENCE; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RHIZOBIUM;

BACTERIA (MICROORGANISMS);

EID: 84857534559     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2011.12.019     Document Type: Article

References (59)

1. C. Agrawal-Gamse, R.J. Luallen, B. Liu, H. Fu, F.-H. Lee, Y. Geng, and R.W. Doms Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans J. Virol. 85 2011 470 480
2. R.D. Astronomo, and D.R. Burton Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat. Rev. Drug Discov. 9 2010 308 324
3. R.D. Astronomo, H.-K. Lee, C.N. Scanlan, R. Pantophlet, C.-Y. Huang, I.A. Wilson, O. Blixt, R.A. Dwek, C.-H. Wong, and D.R. Burton A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120 J. Virol. 82 2008 6359 6368 (Pubitemid 351875114)
4. R.D. Astronomo, E. Kaltgrad, A.K. Udit, S.K. Wang, K.J. Doores, C.Y. Huang, R. Pantophlet, J.C. Paulson, C.H. Wong, M.G. Finn, and D.R. Burton Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds Chem. Biol. 17 2010 357 370
5. J.M. Binley, T. Wrin, B. Korber, M.B. Zwick, M. Wang, C. Chappey, G. Stiegler, R. Kunert, S. Zolla-Pazner, and H. Katinger Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies J. Virol. 78 2004 13232 13252 (Pubitemid 39507829)
6. A. Björndal, H. Deng, M. Jansson, J.R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D.R. Littman, and E.M. Fenyö Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype J. Virol. 71 1997 7478 7487 (Pubitemid 27391688)
7. G. Blanchard-Rohner, and A.J. Pollard Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy Expert Rev. Vaccines 10 2011 673 684
8. M.W. Breedveld, and K.J. Miller Cyclic beta-glucans of members of the family Rhizobiaceae Microbiol. Rev. 58 1994 145 161
9. D.R. Burton, R.C. Desrosiers, R.W. Doms, W.C. Koff, P.D. Kwong, J.P. Moore, G.J. Nabel, J. Sodroski, I.A. Wilson, and R.T. Wyatt HIV vaccine design and the neutralizing antibody problem Nat. Immunol. 5 2004 233 236 (Pubitemid 38332116)
10. D.A. Calarese, C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, and K.H. Roux Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300 2003 2065 2071 (Pubitemid 36760127)
11. D.A. Calarese, H.K. Lee, C.Y. Huang, M.D. Best, R.D. Astronomo, R.L. Stanfield, H. Katinger, D.R. Burton, C.H. Wong, and I.A. Wilson Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 Proc. Natl. Acad. Sci. USA 102 2005 13372 13377 (Pubitemid 41420854)
12. L.J. Chang, V. Urlacher, T. Iwakuma, Y. Cui, and J. Zucali Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system Gene Ther. 6 1999 715 728 (Pubitemid 29243643)
13. R.I. Connor, B.K. Chen, S. Choe, and N.R. Landau Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206 1995 935 944
14. M. Curvall, B. Lindberg, J. Lönngren, and W. Nimmich Structural studies on the Klebsiella O group 3 lipopolysaccharide Acta Chem. Scand. 27 1973 2645 2649
15. C. De Castro, A. Molinaro, R. Lanzetta, A. Silipo, and M. Parrilli Lipopolysaccharide structures from Agrobacterium and Rhizobiaceae species Carbohydr. Res. 343 2008 1924 1933
16. C. De Castro, M. Parrilli, O. Holst, and A. Molinaro Microbe-associated molecular patterns in innate immunity: extraction and chemical analysis of gram-negative bacterial lipopolysaccharides Methods Enzymol. 480 2010 89 115
17. K.J. Doores, C. Bonomelli, D.J. Harvey, S. Vasiljevic, R.A. Dwek, D.R. Burton, M. Crispin, and C.N. Scanlan Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens Proc. Natl. Acad. Sci. USA 107 2010 13800 13805
18. K.J. Doores, Z. Fulton, M. Huber, I.A. Wilson, and D.R. Burton Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged J. Virol. 84 2010 10690 10699
19. K.J. Doores, Z. Fulton, V. Hong, M.K. Patel, C.N. Scanlan, M.R. Wormald, M.G. Finn, D.R. Burton, I.A. Wilson, and B.G. Davis A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity Proc. Natl. Acad. Sci. USA 107 2010 17107 17112
20. D.C. Dunlop, C. Bonomelli, F. Mansab, S. Vasiljevic, K.J. Doores, M.R. Wormald, A.S. Palma, T. Feizi, D.J. Harvey, and R.A. Dwek Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans Glycobiology 20 2010 812 823
21. A. Finn Bacterial polysaccharide-protein conjugate vaccines Br. Med. Bull. 70 2004 1 14 (Pubitemid 40069369)
22. C. Galanos, O. Lüderitz, and O. Westphal A new method for the extraction of R lipopolysaccharides Eur. J. Biochem. 9 1969 245 249
23. J. He, S. Choe, R. Walker, P. Di Marzio, D.O. Morgan, and N.R. Landau Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity J. Virol. 69 1995 6705 6711
24. P.T. Heath An update on vaccination against group B streptococcus Expert Rev. Vaccines 10 2011 685 694
25. P.J. Hitchcock, and T.M. Brown Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels J. Bacteriol. 154 1983 269 277 (Pubitemid 13115445)
26. O. Holst Deacylation of lipopolysaccharides and isolation of oligosaccharide phosphates Methods Mol. Biol. 145 2000 345 353
27. O. Holst, K. Bock, L. Brade, and H. Brade The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC Eur. J. Biochem. 229 1995 194 200
28. L.A. Hunt, J.R. Etchison, and D.F. Summers Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus Proc. Natl. Acad. Sci. USA 75 1978 754 758 (Pubitemid 8319452)
29. P.E. Jansson, J. Lönngren, G. Widmalm, K. Leontein, K. Slettengren, S.B. Svenson, G. Wrangsell, A. Dell, and P.R. Tiller Structural studies of the O-antigen polysaccharides of Klebsiella O5 and Escherichia coli O8 Carbohydr. Res. 145 1985 59 66
30. M.I. Johnston, and A.S. Fauci An HIV vaccine - challenges and prospects N. Engl. J. Med. 359 2008 888 890
31. J.G. Joyce, I.J. Krauss, H.C. Song, D.W. Opalka, K.M. Grimm, D.D. Nahas, M.T. Esser, R. Hrin, M. Feng, and V.Y. Dudkin An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions Proc. Natl. Acad. Sci. USA 105 2008 15684 15689
32. E. Katzenellenbogen, N.A. Kocharova, G.V. Zatonsky, J. Kübler-Kiełb, A. Gamian, A.S. Shashkov, Y.A. Knirel, and E. Romanowska Structural and serological studies on Hafnia alvei O-specific polysaccharide of alpha-D-mannan type isolated from the lipopolysaccharide of strain PCM 1223 FEMS Immunol. Med. Microbiol. 30 2001 223 227 (Pubitemid 32373297)
33. R. Kittelberger, and F. Hilbink Sensitive silver-staining detection of bacterial lipopolysaccharides in polyacrylamide gels J. Biochem. Biophys. Methods 26 1993 81 86 (Pubitemid 23047958)
34. M. Kjaer, K.V. Andersen, and F.M. Poulsen Automated and semiautomated analysis of homo- and heteronuclear multidimensional nuclear magnetic resonance spectra of proteins: the program Pronto Methods Enzymol. 239 1994 288 307
35. H.K. Lee, C.N. Scanlan, C.Y. Huang, A.Y. Chang, D.A. Calarese, R.A. Dwek, P.M. Rudd, D.R. Burton, I.A. Wilson, and C.H. Wong Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody Angew. Chem. Int. Ed. Engl. 43 2004 1000 1003 (Pubitemid 39258001)
36. H. Li, and L.X. Wang Design and synthesis of a template-assembled oligomannose cluster as an epitope mimic for human HIV-neutralizing antibody 2G12 Org. Biomol. Chem. 2 2004 483 488
37. M. Li, F. Gao, J.R. Mascola, L. Stamatatos, V.R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, and K.M. Greene Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies J. Virol. 79 2005 10108 10125 (Pubitemid 41098552)
38. B. Lindberg, J. Lönngren, and W. Nimmich Structural studies on Klebsiella O group 5 lipopolysaccharides Acta Chem. Scand. 26 1972 2231 2236
39. R.J. Luallen, J. Lin, H. Fu, K.K. Cai, C. Agrawal, I. Mboudjeka, F.-H. Lee, D. Montefiori, D.F. Smith, R.W. Doms, and Y. Geng An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies J. Virol. 82 2008 6447 6457 (Pubitemid 351875122)
40. R.J. Luallen, C. Agrawal-Gamse, H. Fu, D.F. Smith, R.W. Doms, and Y. Geng Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains Glycobiology 20 2010 280 286
41. A.H. Lucas, K. Rittenhouse-Olson, M. Kronenberg, M.A. Apicella, D. Wang, J.R. Schreiber, and C.E. Taylor Carbohydrate moieties as vaccine candidates: meeting summary Vaccine 28 2010 1121 1131
42. J. Ni, H. Song, Y. Wang, N.M. Stamatos, and L.-X. Wang Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates Bioconjug. Chem. 17 2006 493 500
43. R. Pantophlet, L. Brade, L. Dijkshoorn, and H. Brade Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter J. Clin. Microbiol. 36 1998 1245 1250 (Pubitemid 28208007)
44. R. Pantophlet, E. Ollmann Saphire, P. Poignard, P.W. Parren, I.A. Wilson, and D.R. Burton Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 J. Virol. 77 2003 642 658 (Pubitemid 36005001)
45. P. Prehm, B. Jann, and K. Jann The O9 antigen of Escherichia coli Structure of the polysaccharide chain Eur. J. Biochem. 67 1976 53 56
46. R.W. Sanders, M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K.O. Lloyd, P.D. Kwong, and J.P. Moore The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J. Virol. 76 2002 7293 7305
47. C.N. Scanlan, R. Pantophlet, M.R. Wormald, E. Ollmann Saphire, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, P.M. Rudd, and D.R. Burton The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120 J. Virol. 76 2002 7306 7321
48. C.N. Scanlan, G.E. Ritchie, K. Baruah, M. Crispin, D.J. Harvey, B.B. Singer, L. Lucka, M.R. Wormald, P. Wentworth Jr., and N. Zitzmann Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody J. Mol. Biol. 372 2007 16 22 (Pubitemid 47225174)
49. M.S. Seaman, H. Janes, N. Hawkins, L.E. Grandpre, C. Devoy, A. Giri, R.T. Coffey, L. Harris, B. Wood, and M.G. Daniels Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies J. Virol. 84 2010 1439 1452
50. A. Silipo, C. De Castro, R. Lanzetta, A. Molinaro, and M. Parrilli Full structural characterization of the lipid A components from the Agrobacterium tumefaciens strain C58 lipopolysaccharide fraction Glycobiology 14 2004 805 815 (Pubitemid 39206883)
51. E. Stansell, and R.C. Desrosiers Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages J. Virol. 84 2010 8998 9009
52. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, and H. Katinger Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J. Virol. 70 1996 1100 1108 (Pubitemid 26029030)
53. J.F.G. Vliegenthart Carbohydrate based vaccines FEBS Lett. 580 2006 2945 2950 (Pubitemid 43729166)
54. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, J.-P. Julien, S.-K. Wang, A. Ramos, P.-Y. Chan-Hui, M. Moyle Protocol G Principal Investigators Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
55. L.X. Wang, J. Ni, S. Singh, and H. Li Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design Chem. Biol. 11 2004 127 134 (Pubitemid 38203997)
56. J. Wang, H. Li, G. Zou, and L.X. Wang Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study Org. Biomol. Chem. 5 2007 1529 1540 (Pubitemid 46959421)
57. O. Westphal, and K. Jann Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure R.L. Whistler, Methods in Carnohydrate Chemistry 1965 Academic Press New York 83 91
58. R. Wyatt, P.D. Kwong, E. Desjardins, R.W. Sweet, J. Robinson, W.A. Hendrickson, and J.G. Sodroski The antigenic structure of the HIV gp120 envelope glycoprotein Nature 393 1998 705 711 (Pubitemid 28289663)
59. M.B. Zwick, M. Wang, P. Poignard, G. Stiegler, H. Katinger, D.R. Burton, and P.W. Parren Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies J. Virol. 75 2001 12198 12208 (Pubitemid 33115893)